Impact of low serum hemoglobin on development of contrast-induced nephropathy (CIN) in patients with hepatocellular carcinoma (HCC) following transarterial chemoembolisation (TACE)
ConclusionsLow Hb is an independent risk factor for post-TACE CIN. Therefore, HCC patients with low Hb levels should be closely monitored before and during TACE.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hypertension | Liver Cancer | Urology & Nephrology